PTPRC | protein tyrosine phosphatase, receptor type, C | 1q31-q32 | 1.203 | 0.905 | 0
|
SASH3 | SAM and SH3 domain containing 3 | Xq26 | 1.162 | 0.896 | 0
|
EVI2B | ecotropic viral integration site 2B | 17q11.2 | 1.128 | 0.894 | 0
|
DOCK2 | dedicator of cytokinesis 2 | 5q35.1 | 1.089 | 0.891 | 0
|
CD48 | CD48 molecule | 1q21.3-q22 | 1.066 | 0.878 | 0
|
ITGAL | integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) | 16p13.1-p11 | 1.062 | 0.882 | 0
|
SLAMF6 | SLAM family member 6 | 1q23.1 | 1.059 | 0.896 | 0
|
CD53 | CD53 molecule | 1p13 | 1.033 | 0.873 | 0
|
ITK | IL2-inducible T-cell kinase | 5q31-q32 | 1.026 | 0.885 | 0
|
WDFY4 | WDFY family member 4 | 10q11.23 | 1.024 | 0.869 | 0
|
P2RY10 | purinergic receptor P2Y, G-protein coupled, 10 | Xq21.1 | 1.02 | 0.862 | 0
|
NCKAP1L | NCK-associated protein 1-like | 12q13.1 | 1.019 | 0.871 | 0
|
SPN | sialophorin | 16p11.2 | 1.018 | 0.881 | 0
|
IL10RA | interleukin 10 receptor, alpha | 11q23 | 1.014 | 0.885 | 0
|
BTK | Bruton agammaglobulinemia tyrosine kinase | Xq21.33-q22 | 0.999 | 0.86 | 0
|
BIN2 | bridging integrator 2 | 12q13.13 | 0.998 | 0.863 | 0
|
SLAMF1 | signaling lymphocytic activation molecule family member 1 | 1q23.3 | 0.996 | 0.874 | 0
|
IRF8 | interferon regulatory factor 8 | 16q24.1 | 0.99 | 0.85 | 0
|
RHOH | ras homolog family member H | 4p13 | 0.989 | 0.866 | 0
|
CD3E | CD3e molecule, epsilon (CD3-TCR complex) | 11q23 | 0.982 | 0.873 | 0
|
CD5 | CD5 molecule | 11q13 | 0.968 | 0.842 | 0
|
GPR65 | G protein-coupled receptor 65 | 14q31-q32.1 | 0.967 | 0.858 | 0
|
CD37 | CD37 molecule | 19p13-q13.4 | 0.965 | 0.876 | 0
|
PLEK | pleckstrin | 2p13.3 | 0.963 | 0.87 | 0
|
SH2D1A | SH2 domain containing 1A | Xq25 | 0.958 | 0.873 | 0
|
DOCK10 | dedicator of cytokinesis 10 | 2q36.3 | 0.956 | 0.862 | 0
|
PTPN7 | protein tyrosine phosphatase, non-receptor type 7 | 1q32.1 | 0.956 | 0.862 | 0
|
IL21R | interleukin 21 receptor | 16p11 | 0.95 | 0.858 | 0
|
ARHGAP9 | Rho GTPase activating protein 9 | 12q13.3 | 0.949 | 0.868 | 0
|
WAS | Wiskott-Aldrich syndrome | Xp11.4-p11.21 | 0.947 | 0.87 | 0
|
SLA | Src-like-adaptor | 8q24.22 | 0.936 | 0.852 | 0
|
BTLA | B and T lymphocyte associated | 3q13.2 | 0.928 | 0.849 | 0
|
SIT1 | signaling threshold regulating transmembrane adaptor 1 | 9p13-p12 | 0.927 | 0.845 | 0
|
UBASH3A | ubiquitin associated and SH3 domain containing A | 21q22.3 | 0.919 | 0.853 | 0
|
SELPLG | selectin P ligand | 12q24 | 0.917 | 0.855 | 0
|
PYHIN1 | pyrin and HIN domain family, member 1 | 1q23.1 | 0.917 | 0.857 | 0
|
ZNF831 | zinc finger protein 831 | 20q13.32 | 0.916 | 0.86 | 0
|
CYTIP | cytohesin 1 interacting protein | 2q11.2 | 0.915 | 0.863 | 0
|
CD2 | CD2 molecule | 1p13 | 0.913 | 0.868 | 0
|
SNX20 | sorting nexin 20 | 16q12.1 | 0.913 | 0.835 | 0
|
CD52 | CD52 molecule | 1p36 | 0.909 | 0.85 | 0
|
LCP2 | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) | 5q35.1 | 0.894 | 0.86 | 0
|
TBC1D10C | TBC1 domain family, member 10C | 11q13.1 | 0.891 | 0.847 | 0
|
CD27 | CD27 molecule | 12p13 | 0.888 | 0.848 | 0
|
TAGAP | T-cell activation RhoGTPase activating protein | 6q25.3 | 0.888 | 0.829 | 0
|
CD28 | CD28 molecule | 2q33 | 0.881 | 0.845 | 0
|
TRAT1 | T cell receptor associated transmembrane adaptor 1 | 3q13 | 0.875 | 0.818 | 0
|
CCR5 | chemokine (C-C motif) receptor 5 (gene/pseudogene) | 3p21 | 0.875 | 0.843 | 0
|
ACAP1 | ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 | 17p13.1 | 0.869 | 0.851 | 0
|
CELF2 | CUGBP, Elav-like family member 2 | 10p13 | 0.862 | 0.771 | 0
|
GZMK | granzyme K (granzyme 3; tryptase II) | 5q11.2 | 0.851 | 0.835 | 0
|
RASAL3 | RAS protein activator like 3 | 19p13.12 | 0.85 | 0.836 | 0
|
GRAP2 | GRB2-related adaptor protein 2 | 22q13.2 | 0.849 | 0.828 | 0
|
CXCR3 | chemokine (C-X-C motif) receptor 3 | Xq13 | 0.848 | 0.84 | 0
|
GAB3 | GRB2-associated binding protein 3 | Xq28 | 0.839 | 0.835 | 0
|
GVINP1 | GTPase, very large interferon inducible pseudogene 1 | 11p15.4 | 0.839 | 0.848 | 0
|
IL2RG | interleukin 2 receptor, gamma | Xq13 | 0.834 | 0.8 | 0
|
LY9 | lymphocyte antigen 9 | 1q23.3 | 0.834 | 0.806 | 0
|
ZAP70 | zeta-chain (TCR) associated protein kinase 70kDa | 2q11-q13 | 0.831 | 0.794 | 0
|
APBB1IP | amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein | 10p12.1 | 0.829 | 0.708 | 0
|
TESPA1 | thymocyte expressed, positive selection associated 1 | 12q13.2 | 0.829 | 0.773 | 0
|
PTPN22 | protein tyrosine phosphatase, non-receptor type 22 (lymphoid) | 1p13.2 | 0.821 | 0.832 | 0
|
WIPF1 | WAS/WASL interacting protein family, member 1 | 2q31.2 | 0.813 | 0.801 | 0
|
CD6 | CD6 molecule | 11q12.2 | 0.811 | 0.804 | 0
|
IL12RB1 | interleukin 12 receptor, beta 1 | 19p13.1 | 0.81 | 0.811 | 0
|
IRF4 | interferon regulatory factor 4 | 6p25-p23 | 0.81 | 0.824 | 0
|
NLRC3 | NLR family, CARD domain containing 3 | 16p13.3 | 0.808 | 0.837 | 0
|
NCF1C | neutrophil cytosolic factor 1C pseudogene | 7q11.23 | 0.802 | 0.81 | 0
|
RUNX3 | runt-related transcription factor 3 | 1p36 | 0.802 | 0.759 | 0
|
LCK | LCK proto-oncogene, Src family tyrosine kinase | 1p34.3 | 0.802 | 0.788 | 0
|
TRAF3IP3 | TRAF3 interacting protein 3 | 1q32.3-q41 | 0.797 | 0.808 | 0
|
MAP4K1 | mitogen-activated protein kinase kinase kinase kinase 1 | 19q13.1-q13.4 | 0.797 | 0.808 | 0
|
TIGIT | T cell immunoreceptor with Ig and ITIM domains | 3q13.31 | 0.791 | 0.834 | 0
|
RCSD1 | RCSD domain containing 1 | 1q24.2 | 0.789 | 0.779 | 0
|
SLA2 | Src-like-adaptor 2 | 20q11.23 | 0.787 | 0.833 | 0
|
LINC00426 | long intergenic non-protein coding RNA 426 | 13q12.3 | 0.782 | 0.823 | 0
|
PDCD1 | programmed cell death 1 | 2q37.3 | 0.781 | 0.826 | 0
|
CST7 | cystatin F (leukocystatin) | 20p11.21 | 0.781 | 0.806 | 0
|
PPP1R16B | protein phosphatase 1, regulatory subunit 16B | 20q11.23 | 0.776 | 0.792 | 0
|
CD3D | CD3d molecule, delta (CD3-TCR complex) | 11q23 | 0.774 | 0.776 | 0
|
ICOS | inducible T-cell co-stimulator | 2q33 | 0.771 | 0.807 | 0
|
THEMIS | thymocyte selection associated | 6q22.33 | 0.767 | 0.821 | 0
|
CD226 | CD226 molecule | 18q22.3 | 0.766 | 0.811 | 0
|
KLHL6 | kelch-like family member 6 | 3q27.3 | 0.751 | 0.762 | 0
|
CD247 | CD247 molecule | 1q24.2 | 0.745 | 0.795 | 0
|
FUT7 | fucosyltransferase 7 (alpha (1,3) fucosyltransferase) | 9q34.3 | 0.743 | 0.771 | 0
|
LTA | lymphotoxin alpha | 6p21.3 | 0.743 | 0.799 | 0
|
TIFAB | TRAF-interacting protein with forkhead-associated domain, family member B | 5q31.1 | 0.742 | 0.783 | 0
|
CCR2 | chemokine (C-C motif) receptor 2 | 3p21 | 0.741 | 0.785 | 0
|
JAKMIP1 | janus kinase and microtubule interacting protein 1 | 4p16.1 | 0.74 | 0.787 | 0
|
IL2RB | interleukin 2 receptor, beta | 22q13 | 0.735 | 0.79 | 0
|
CD38 | CD38 molecule | 4p15.32 | 0.731 | 0.763 | 0
|
TBX21 | T-box 21 | 17q21.32 | 0.731 | 0.809 | 0
|
CD3G | CD3g molecule, gamma (CD3-TCR complex) | 11q23 | 0.729 | 0.811 | 0
|
AMICA1 | adhesion molecule, interacts with CXADR antigen 1 | 11q23.3 | 0.727 | 0.802 | 0
|
SIRPG | signal-regulatory protein gamma | 20p13 | 0.726 | 0.753 | 0
|
ARHGAP15 | Rho GTPase activating protein 15 | 2q22.2-q22.3 | 0.725 | 0.742 | 0
|
CXCR6 | chemokine (C-X-C motif) receptor 6 | 3p21 | 0.723 | 0.781 | 0
|
SP140 | SP140 nuclear body protein | 2q37.1 | 0.719 | 0.774 | 0
|
GPR174 | G protein-coupled receptor 174 | Xq13.3 | 0.719 | 0.768 | 0
|
NAPSB | napsin B aspartic peptidase, pseudogene | 19q13.33 | 0.719 | 0.77 | 0
|
SAMD3 | sterile alpha motif domain containing 3 | 6q23.1 | 0.715 | 0.796 | 0
|
C16orf54 | chromosome 16 open reading frame 54 | 16p11.2 | 0.711 | 0.578 | 0
|
ZC3H12D | zinc finger CCCH-type containing 12D | 6q25.1 | 0.709 | 0.771 | 0
|
ARHGAP25 | Rho GTPase activating protein 25 | 2p13.3 | 0.705 | 0.73 | 0
|
ADGRG5 | adhesion G protein-coupled receptor G5 | 16q13 | 0.702 | 0.761 | 0
|
FYB | FYN binding protein | 5p13.1 | 0.7 | 0.706 | 0
|
SPOCK2 | sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 | 10q22.1 | 0.698 | 0.723 | 0
|
ABCD2 | ATP-binding cassette, sub-family D (ALD), member 2 | 12q12 | 0.691 | 0.773 | 0
|
CORO1A | coronin, actin binding protein, 1A | 16p11.2 | 0.689 | 0.762 | 0
|
GNG2 | guanine nucleotide binding protein (G protein), gamma 2 | 14q21 | 0.681 | 0.735 | 0
|
CXCL13 | chemokine (C-X-C motif) ligand 13 | 4q21 | 0.677 | 0.732 | 0
|
PCED1B-AS1 | PCED1B antisense RNA 1 | 12q13.11 | 0.668 | 0.751 | 0
|
PRKCB | protein kinase C, beta | 16p12 | 0.666 | 0.67 | 0
|
LTB | lymphotoxin beta (TNF superfamily, member 3) | 6p21.3 | 0.665 | 0.763 | 0
|
DCANP1 | dendritic cell-associated nuclear protein | 5q31.1 | 0.665 | 0.752 | 0
|
CCR4 | chemokine (C-C motif) receptor 4 | 3p24-p21.3 | 0.664 | 0.75 | 0
|
VAV1 | vav 1 guanine nucleotide exchange factor | 19p13.3 | 0.661 | 0.659 | 0
|
EOMES | eomesodermin | 3p24.1 | 0.656 | 0.733 | 0
|
CLECL1 | C-type lectin-like 1 | 12p13.31 | 0.654 | 0.76 | 0
|
GPR18 | G protein-coupled receptor 18 | 13q32 | 0.647 | 0.717 | 0
|
NCR3 | natural cytotoxicity triggering receptor 3 | 6p21.3 | 0.645 | 0.772 | 0
|
MEI1 | meiotic double-stranded break formation protein 1 | 22q13.2 | 0.643 | 0.717 | 0
|
FOXP3 | forkhead box P3 | Xp11.23 | 0.633 | 0.748 | 0
|
IL16 | interleukin 16 | 15q26.3 | 0.631 | 0.713 | 0
|
KLRB1 | killer cell lectin-like receptor subfamily B, member 1 | 12p13 | 0.631 | 0.767 | 0
|
IL18RAP | interleukin 18 receptor accessory protein | 2q12.1 | 0.629 | 0.722 | 0
|
STAT4 | signal transducer and activator of transcription 4 | 2q32.2-q32.3 | 0.621 | 0.727 | 0
|
S1PR4 | sphingosine-1-phosphate receptor 4 | 19p13.3 | 0.62 | 0.649 | 0
|
SEPT1 | septin 1 | 16p11.2 | 0.618 | 0.688 | 0
|
LPXN | leupaxin | 11q12.1 | 0.617 | 0.64 | 0
|
IL7R | interleukin 7 receptor | 5p13 | 0.616 | 0.713 | 0
|
GIMAP7 | GTPase, IMAP family member 7 | 7q36.1 | 0.61 | 0.737 | 0
|
GPR132 | G protein-coupled receptor 132 | 14q32.3 | 0.61 | 0.694 | 0
|
FLT3 | fms-related tyrosine kinase 3 | 13q12 | 0.606 | 0.735 | 0
|
C11orf21 | chromosome 11 open reading frame 21 | 11p15.5 | 0.605 | 0.731 | 0
|
CIITA | class II, major histocompatibility complex, transactivator | 16p13 | 0.605 | 0.693 | 0
|
MIR155HG | MIR155 host gene | 21q21.3 | 0.605 | 0.745 | 0
|
CD69 | CD69 molecule | 12p13 | 0.604 | 0.62 | 0
|
TLR10 | toll-like receptor 10 | 4p14 | 0.604 | 0.735 | 0
|
TMC8 | transmembrane channel-like 8 | 17q25.3 | 0.602 | 0.703 | 0
|
PIK3CG | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma | 7q22 | 0.6 | 0.74 | 0
|
HLA-DOA | major histocompatibility complex, class II, DO alpha | 6p21.3 | 0.596 | 0.689 | 0
|
TOX | thymocyte selection-associated high mobility group box | 8q12.2-q12.3 | 0.595 | 0.668 | 0
|
LGALS2 | lectin, galactoside-binding, soluble, 2 | 22q13.1 | 0.589 | 0.714 | 0
|
PRKCQ | protein kinase C, theta | 10p15 | 0.589 | 0.482 | 0
|
JAK3 | Janus kinase 3 | 19p13-p12 | 0.587 | 0.653 | 0
|
FLI1 | Fli-1 proto-oncogene, ETS transcription factor | 11q24.1-q24.3 | 0.586 | 0.745 | 0
|
VNN2 | vanin 2 | 6q23-q24 | 0.582 | 0.696 | 0
|
P2RY8 | purinergic receptor P2Y, G-protein coupled, 8 | Xp22.33 and Yp11.3 | 0.582 | 0.692 | 0
|
KCNAB2 | potassium channel, voltage gated subfamily A regulatory beta subunit 2 | 1p36.3 | 0.57 | 0.61 | 0
|
CCR6 | chemokine (C-C motif) receptor 6 | 6q27 | 0.55 | 0.696 | 0
|
GAPT | GRB2-binding adaptor protein, transmembrane | 5q11.2 | 0.549 | 0.698 | 0
|
HLA-DOB | major histocompatibility complex, class II, DO beta | 6p21.3 | 0.549 | 0.658 | 0
|
PARP15 | poly (ADP-ribose) polymerase family, member 15 | 3q21 | 0.545 | 0.673 | 0
|
PIP4K2A | phosphatidylinositol-5-phosphate 4-kinase, type II, alpha | 10p12.2 | 0.544 | 0.657 | 0
|
CXCR4 | chemokine (C-X-C motif) receptor 4 | 2q21 | 0.543 | 0.687 | 0
|
CD200R1 | CD200 receptor 1 | 3q13 | 0.538 | 0.699 | 0
|
PREX1 | phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1 | 20q13.13 | 0.537 | 0.566 | 0
|
DENND1C | DENN/MADD domain containing 1C | 19p13.3 | 0.53 | 0.651 | 0
|
SPIB | Spi-B transcription factor (Spi-1/PU.1 related) | 19q13.3-q13.4 | 0.527 | 0.669 | 0
|
GPR55 | G protein-coupled receptor 55 | 2q37 | 0.517 | 0.685 | 0
|
CCDC141 | coiled-coil domain containing 141 | 2q31.2 | 0.516 | 0.662 | 0
|
TRAF1 | TNF receptor-associated factor 1 | 9q33-q34 | 0.515 | 0.628 | 0
|
GPRIN3 | GPRIN family member 3 | 4q22.1 | 0.514 | 0.678 | 0
|
TCL1A | T-cell leukemia/lymphoma 1A | 14q32.1 | 0.511 | 0.617 | 0
|
SYT11 | synaptotagmin XI | 1q22 | 0.509 | 0.628 | 0
|
LRRK2 | leucine-rich repeat kinase 2 | 12q12 | 0.507 | 0.663 | 0
|
MCOLN2 | mucolipin 2 | 1p22 | 0.501 | 0.576 | 0
|
ADORA2A | adenosine A2a receptor | 22q11.23 | 0.496 | 0.614 | 0
|
MARCH1 | membrane-associated ring finger (C3HC4) 1, E3 ubiquitin protein ligase | 4q32.2 | 0.493 | 0.596 | 0
|
CFP | complement factor properdin | Xp11.4 | 0.489 | 0.633 | 0
|
BIRC3 | baculoviral IAP repeat containing 3 | 11q22 | 0.483 | 0.621 | 0
|
RASGRP1 | RAS guanyl releasing protein 1 (calcium and DAG-regulated) | 15q15 | 0.476 | 0.617 | 0
|
CYSLTR1 | cysteinyl leukotriene receptor 1 | Xq13-q21 | 0.475 | 0.628 | 0
|
P2RX7 | purinergic receptor P2X, ligand gated ion channel, 7 | 12q24 | 0.472 | 0.606 | 0
|
ST6GAL1 | ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 | 3q27.3 | 0.471 | 0.652 | 0
|
KCTD12 | potassium channel tetramerization domain containing 12 | 13q21 | 0.47 | 0.607 | 0
|
RAB37 | RAB37, member RAS oncogene family | 17q25.2 | 0.469 | 0.641 | 0
|
SARDH | sarcosine dehydrogenase | 9q33-q34 | 0.465 | 0.576 | 0
|
LCP1 | lymphocyte cytosolic protein 1 (L-plastin) | 13q14.3 | 0.463 | 0.566 | 0
|
LOC100130872 | | | 0.461 | 0.575 | 0
|
ZNF804A | zinc finger protein 804A | 2q32.1 | 0.459 | 0.6 | 0
|
ARHGAP30 | Rho GTPase activating protein 30 | 1q23.3 | 0.458 | 0.569 | 0
|
POU2F2 | POU class 2 homeobox 2 | 19q13.2 | 0.45 | 0.611 | 0
|
PLCL2 | phospholipase C-like 2 | 3p24.3 | 0.45 | 0.513 | 0
|
ANKRD29 | ankyrin repeat domain 29 | 18q11.2 | 0.449 | 0.605 | 0
|
SEPT6 | septin 6 | Xq24 | 0.447 | 0.609 | 0
|
PLXNC1 | plexin C1 | 12q23 | 0.447 | 0.595 | 0
|
PVRIG | poliovirus receptor related immunoglobulin domain containing | 7q22.1 | 0.446 | 0.568 | 0
|
CAMK4 | calcium/calmodulin-dependent protein kinase IV | 5q22.1 | 0.444 | 0.568 | 0
|
LOC100129034 | | | 0.436 | 0.531 | 0
|
TLR6 | toll-like receptor 6 | 4p16.1 | 0.435 | 0.589 | 0
|
P2RY12 | purinergic receptor P2Y, G-protein coupled, 12 | 3q25.1 | 0.434 | 0.601 | 0
|
SAMHD1 | SAM domain and HD domain 1 | 20q11.23 | 0.433 | 0.582 | 0
|
AKNA | AT-hook transcription factor | 9q32 | 0.43 | 0.562 | 0
|
HRH2 | histamine receptor H2 | 5q35 | 0.429 | 0.593 | 0
|
RLTPR | RGD motif, leucine rich repeats, tropomodulin domain and proline-rich containing | 16q22.1 | 0.426 | 0.452 | 0
|
IGF1 | insulin-like growth factor 1 (somatomedin C) | 12q23.2 | 0.425 | 0.537 | 0
|
SFMBT2 | Scm-like with four mbt domains 2 | 10p15.1 | 0.423 | 0.561 | 0
|
SLCO5A1 | solute carrier organic anion transporter family, member 5A1 | 8q13.1 | 0.421 | 0.554 | 0
|
SNAI3 | snail family zinc finger 3 | 16q24.3 | 0.421 | 0.474 | 0
|
KCNQ5 | potassium channel, voltage gated KQT-like subfamily Q, member 5 | 6q14 | 0.42 | 0.519 | 0
|
ANKRD44 | ankyrin repeat domain 44 | 2q33.1 | 0.417 | 0.607 | 0
|
RASGEF1B | RasGEF domain family, member 1B | 4q21.21 | 0.407 | 0.524 | 0
|
RGS9 | regulator of G-protein signaling 9 | 17q24 | 0.404 | 0.566 | 0
|
CLIC2 | chloride intracellular channel 2 | Xq28 | 0.404 | 0.605 | 0
|
ITPRIPL1 | inositol 1,4,5-trisphosphate receptor interacting protein-like 1 | 2q11.2 | 0.402 | 0.406 | 0
|
SUCNR1 | succinate receptor 1 | 3q25.1 | 0.402 | 0.467 | 0
|
FNBP1 | formin binding protein 1 | 9q34 | 0.401 | 0.552 | 0
|
TMEM71 | transmembrane protein 71 | 8q24.22 | 0.395 | 0.546 | 0
|
PTGER2 | prostaglandin E receptor 2 (subtype EP2), 53kDa | 14q22 | 0.393 | 0.571 | 0
|
C5orf58 | chromosome 5 open reading frame 58 | 5q35.1 | 0.391 | 0.498 | 0
|
GIMAP2 | GTPase, IMAP family member 2 | 7q36.1 | 0.389 | 0.556 | 0
|
TRABD2A | TraB domain containing 2A | 2p11.2 | 0.387 | 0.552 | 0
|
RAB39B | RAB39B, member RAS oncogene family | Xq28 | 0.382 | 0.364 | 1.09e-14
|
FKBP5 | FK506 binding protein 5 | 6p21.31 | 0.382 | 0.527 | 0
|
LINC00092 | long intergenic non-protein coding RNA 92 | 9q22.32 | 0.378 | 0.553 | 0
|
CFI | complement factor I | 4q25 | 0.375 | 0.531 | 0
|
STAC | SH3 and cysteine rich domain | 3p22.3 | 0.373 | 0.414 | 0
|
SMAP2 | small ArfGAP2 | 1p35.3-p34.1 | 0.371 | 0.537 | 0
|
CR2 | complement component (3d/Epstein Barr virus) receptor 2 | 1q32 | 0.369 | 0.514 | 0
|
KLRG1 | killer cell lectin-like receptor subfamily G, member 1 | 12p13.31 | 0.369 | 0.529 | 0
|
RHOF | ras homolog family member F (in filopodia) | 12q24.31 | 0.366 | 0.398 | 0
|
IL18R1 | interleukin 18 receptor 1 | 2q12 | 0.365 | 0.552 | 0
|
DPF3 | D4, zinc and double PHD fingers, family 3 | 14q24.2 | 0.362 | 0.525 | 0
|
SLC25A53 | solute carrier family 25, member 53 | Xq22.2 | 0.357 | 0.345 | 3.04e-13
|
XCL2 | chemokine (C motif) ligand 2 | 1q24.2 | 0.356 | 0.458 | 0
|
DENND5B | DENN/MADD domain containing 5B | 12p11.21 | 0.356 | 0.416 | 0
|
ADAM28 | ADAM metallopeptidase domain 28 | 8p21.2 | 0.352 | 0.366 | 7.33e-15
|
IPCEF1 | interaction protein for cytohesin exchange factors 1 | 6q25.2 | 0.351 | 0.368 | 4.39e-15
|
NXPE3 | neurexophilin and PC-esterase domain family, member 3 | 3q12.3 | 0.347 | 0.47 | 0
|
LINC01550 | long intergenic non-protein coding RNA 1550 | 14q32.2 | 0.346 | 0.427 | 0
|
KCNJ10 | potassium channel, inwardly rectifying subfamily J, member 10 | 1q23.2 | 0.344 | 0.43 | 0
|
NELFCD | negative elongation factor complex member C/D | 20q13 | 0.339 | -0.466 | 0
|
L3MBTL4 | l(3)mbt-like 4 (Drosophila) | 18p11.31-p11.23 | 0.331 | 0.4 | 0
|
ATP8A1 | ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1 | 4p13 | 0.331 | 0.271 | 1.53e-08
|
BEND4 | BEN domain containing 4 | 4p13 | 0.33 | 0.476 | 0
|
DOCK8 | dedicator of cytokinesis 8 | 9p24.3 | 0.325 | 0.331 | 2.83e-12
|
ATP2A3 | ATPase, Ca++ transporting, ubiquitous | 17p13.3 | 0.325 | 0.371 | 2.24e-15
|
ST3GAL5 | ST3 beta-galactoside alpha-2,3-sialyltransferase 5 | 2p11.2 | 0.322 | -0.171 | 0.000392
|
STAT5A | signal transducer and activator of transcription 5A | 17q11.2 | 0.32 | 0.463 | 0
|
NELL2 | neural EGFL like 2 | 12q12 | 0.319 | 0.296 | 5.19e-10
|
SYNGR3 | synaptogyrin 3 | 16p13.3 | 0.319 | 0.353 | 7.96e-14
|
P2RX5 | purinergic receptor P2X, ligand gated ion channel, 5 | 17p13.3 | 0.318 | 0.44 | 0
|
SLC25A45 | solute carrier family 25, member 45 | 11q13.1 | 0.317 | 0.44 | 0
|
ABCB4 | ATP-binding cassette, sub-family B (MDR/TAP), member 4 | 7q21 | 0.314 | 0.444 | 0
|
ALDH1A1 | aldehyde dehydrogenase 1 family, member A1 | 9q21.13 | 0.312 | 0.405 | 0
|
PADI2 | peptidyl arginine deiminase, type II | 1p35.2-p35.1 | 0.311 | 0.395 | 0
|
COL26A1 | collagen, type XXVI, alpha 1 | 7q22.1 | 0.31 | 0.147 | 0.00236
|
IL20RA | interleukin 20 receptor, alpha | 6q23.3 | 0.308 | -0.381 | 1.61e-16
|
CCRL2 | chemokine (C-C motif) receptor-like 2 | 3p21 | 0.307 | 0.229 | 1.78e-06
|
SLC9A1 | solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1 | 1p36.1-p35 | 0.301 | -0.394 | 0
|
ECEL1 | endothelin converting enzyme-like 1 | 2q37.1 | 0.3 | 0.338 | 9.32e-13
|
CYP2S1 | cytochrome P450, family 2, subfamily S, polypeptide 1 | 19q13.2 | 0.299 | 0.133 | 0.006
|
HLA-DPB2 | major histocompatibility complex, class II, DP beta 2 (pseudogene) | 6p21.3 | 0.298 | 0.428 | 0
|
HLF | hepatic leukemia factor | 17q22 | 0.297 | 0.448 | 0
|
ILVBL | ilvB (bacterial acetolactate synthase)-like | 19p13.1 | 0.295 | -0.463 | 0
|
BCL2 | B-cell CLL/lymphoma 2 | 18q21.3 | 0.291 | 0.383 | 7.94e-17
|
TMEM41A | transmembrane protein 41A | 3q27.2 | 0.291 | -0.286 | 2.03e-09
|
MAP3K14 | mitogen-activated protein kinase kinase kinase 14 | 17q21.31 | 0.288 | 0.462 | 0
|
CSNK1E | casein kinase 1, epsilon | 22q13.1 | 0.288 | -0.389 | 0
|
NAT8B | N-acetyltransferase 8B (GCN5-related, putative, gene/pseudogene) | 2p13.1 | 0.285 | 0.073 | 0.132
|
KIF21B | kinesin family member 21B | 1q32.1 | 0.284 | 0.254 | 1.19e-07
|
RINL | Ras and Rab interactor-like | 19q13.2 | 0.283 | 0.101 | 0.0369
|
SKAP1 | src kinase associated phosphoprotein 1 | 17q21.32 | 0.282 | 0.209 | 1.4e-05
|
DUOX1 | dual oxidase 1 | 15q21 | 0.282 | -0.263 | 3.88e-08
|
BCAP31 | B-cell receptor-associated protein 31 | Xq28 | 0.278 | -0.389 | 0
|
CARD8 | caspase recruitment domain family, member 8 | 19q13.33 | 0.278 | 0.278 | 5.71e-09
|
ADD2 | adducin 2 (beta) | 2p13.3 | 0.278 | 0.341 | 5.71e-13
|
STAG3 | stromal antigen 3 | 7q22 | 0.277 | 0.28 | 4.73e-09
|
LRRC8E | leucine rich repeat containing 8 family, member E | 19p13.2 | 0.277 | -0.33 | 3.6e-12
|
PEX10 | peroxisomal biogenesis factor 10 | 1p36.32 | 0.272 | -0.434 | 0
|
VPS52 | vacuolar protein sorting 52 homolog (S. cerevisiae) | 6p21.3 | 0.27 | -0.381 | 1.89e-16
|
HILPDA | hypoxia inducible lipid droplet-associated | 7q32.1 | 0.27 | -0.403 | 0
|
PKHD1L1 | polycystic kidney and hepatic disease 1 (autosomal recessive)-like 1 | 8q23 | 0.268 | 0.297 | 4.7e-10
|
NFKBID | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, delta | 19q13.12 | 0.266 | 0.045 | 0.357
|
LRRC47 | leucine rich repeat containing 47 | 1p36.32 | 0.266 | -0.295 | 6.48e-10
|
KAT8 | K(lysine) acetyltransferase 8 | 16p11.1 | 0.262 | -0.207 | 1.72e-05
|
FUT4 | fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific) | 11q21 | 0.262 | 0.323 | 1.11e-11
|
TNIK | TRAF2 and NCK interacting kinase | 3q26.31 | 0.26 | 0.329 | 3.94e-12
|
ZNF101 | zinc finger protein 101 | 19p13.11 | 0.26 | 0.209 | 1.39e-05
|
NSUN4 | NOP2/Sun domain family, member 4 | 1p34 | 0.258 | -0.393 | 0
|
N4BP2L1 | NEDD4 binding protein 2-like 1 | 13q13.1 | 0.254 | 0.15 | 0.00193
|
TTBK1 | tau tubulin kinase 1 | 6p21.1 | 0.253 | 0.296 | 5.16e-10
|
KCNH3 | potassium channel, voltage gated eag related subfamily H, member 3 | 12q13 | 0.25 | 0.319 | 1.81e-11
|
TUSC3 | tumor suppressor candidate 3 | 8p22 | 0.25 | -0.362 | 1.6e-14
|
JAKMIP2 | janus kinase and microtubule interacting protein 2 | 5q32 | 0.247 | 0.19 | 8.32e-05
|
LPIN1 | lipin 1 | 2p25.1 | 0.246 | 0.294 | 7.49e-10
|
FAM105A | family with sequence similarity 105, member A | 5p15.2 | 0.245 | 0.214 | 8.99e-06
|
EMB | embigin | 5q11.1 | 0.242 | 0.218 | 5.93e-06
|
TDRD6 | tudor domain containing 6 | 6p12.3 | 0.241 | 0.214 | 8.35e-06
|
PYY2 | peptide YY, 2 (pseudogene) | 17q11 | 0.236 | -0.223 | 3.61e-06
|
RSL24D1 | ribosomal L24 domain containing 1 | 15q21 | 0.221 | -0.216 | 6.74e-06
|
PLCXD2 | phosphatidylinositol-specific phospholipase C, X domain containing 2 | 3q13.2 | 0.217 | 0.197 | 4.31e-05
|
WBSCR27 | Williams Beuren syndrome chromosome region 27 | 7q11.23 | 0.213 | -0.231 | 1.54e-06
|
SYK | spleen tyrosine kinase | 9q22 | 0.191 | 0.262 | 4.51e-08
|